[Adrenocortical adenoma].
Satoh
Fumitoshi
F
Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital.
Ito
Sadayoshi
S
D000306:Adrenal Cortex Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D000315:Adrenalectomy; D018246:Adrenocortical Adenoma / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D000450:Aldosterone / Q000096:biosynthesis; D000728:Androgens / Q000096:biosynthesis; D015415:Biomarkers / Q000032:analysis; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003952:Diagnostic Imaging; D013196:Dihydrotestosterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis / Q000096:biosynthesis; D008797:Metyrapone / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D000728:Androgens; D015415:Biomarkers; D002121:Calcium Channel Blockers; D004791:Enzyme Inhibitors; D013196:Dihydrotestosterone; D013148:Spironolactone; D000450:Aldosterone; C009954:trilostane; D006854:Hydrocortisone; D008797:Metyrapone